Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALEXANDER E GLICK

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1598081911
CMS profile
253026
Location
SARASOTA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$4,720.73

122 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,040.73 120
Consulting Fee $1,680.00 2

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALEXANDER E GLICK

NPI 1598081911 · CMS profile ID 253026

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

SARASOTA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598081911?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598081911?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598081911?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1598081911?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

122 matching records · $4,720.73 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 122 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 122.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $33.1707/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853378 CMS
Novartis Pharmaceuticals Corporation $18.4507/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200324926 CMS
Novartis Pharmaceuticals Corporation $0.6007/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200324928 CMS
Kite Pharma, Inc. $24.6307/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212084159 CMS
SpringWorks Therapeutics, Inc. $29.7007/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232162727 CMS
PFIZER INC. $12.1207/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231676133 CMS
Celgene Corporation $40.6406/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853366 CMS
Eisai Inc. $14.5606/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244457551 CMS
Merck Sharp & Dohme LLC $22.3106/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238075481 CMS
Novartis Pharmaceuticals Corporation $12.6306/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200324924 CMS
PharmaEssentia USA Corporation $20.8406/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246829812 CMS
E.R. Squibb & Sons, L.L.C. $20.5606/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853364 CMS
ARRAY BIOPHARMA INC $15.6706/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231591841 CMS
GENZYME CORPORATION $14.0706/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233489344 CMS
Gilead Sciences, Inc. $24.5106/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234479332 CMS
PFIZER INC. $24.2006/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228809012 CMS
Kite Pharma, Inc. $20.3606/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212084153 CMS
Celltrion USA Inc. $115.0405/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250822974 CMS
Janssen Biotech, Inc. $163.0205/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175239689 CMS
Gilead Sciences, Inc. $27.4005/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234455743 CMS
Astellas Pharma US Inc $23.5105/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238796835 CMS
Merck Sharp & Dohme LLC $27.4205/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238168010 CMS
PFIZER INC. $19.4405/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228985173 CMS
PFIZER INC. $28.4905/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231727754 CMS
Exelixis Inc. $22.6705/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218790351 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.7205/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223854963 CMS
BeOne Medicines USA, Inc. $12.0005/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885564 CMS
Karyopharm Therapeutics Inc. $18.8305/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246641797 CMS
Lilly USA, LLC $24.3805/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186478939 CMS
Daiichi Sankyo Inc. $29.8505/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197065995 CMS
Novartis Pharmaceuticals Corporation $24.4205/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200324922 CMS
Astellas Pharma US Inc $16.7905/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238792107 CMS
Gilead Sciences, Inc. $25.6405/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234468965 CMS
BeOne Medicines USA, Inc. $26.2805/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885562 CMS
PFIZER INC. $23.7404/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228842074 CMS
Celgene Corporation $21.5504/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853346 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.7204/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223894086 CMS
Celgene Corporation $22.4604/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853344 CMS
BeOne Medicines USA, Inc. $24.6304/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885566 CMS
ARRAY BIOPHARMA INC $20.9604/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231586358 CMS
Janssen Biotech, Inc. $16.7804/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175240664 CMS
Merck Sharp & Dohme LLC $28.7004/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237993436 CMS
Celgene Corporation $18.9804/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853350 CMS
E.R. Squibb & Sons, L.L.C. $23.1004/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184853472 CMS
Incyte Corporation $20.8204/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226012889 CMS
Genentech USA, Inc. $15.1803/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211490575 CMS
Myriad Genetic Laboratories, Inc. $13.5803/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245404646 CMS
Gilead Sciences, Inc. $28.1703/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234450079 CMS
Novartis Pharmaceuticals Corporation $21.0303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200324920 CMS
Merck Sharp & Dohme LLC $22.7203/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238168912 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,194.07 152
PY2020 $1,277.71 60
PY2021 $1,553.35 97
PY2022 $2,093.21 107
PY2023 $3,583.61 125
PY2024 $4,308.86 117
PY2025 $4,720.73 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $313,687.93 11
PY2024 Recipient $1,402.00 1
PY2024 Principal investigator $165,343.75 14
PY2023 Recipient $6,838.35 2
PY2023 Principal investigator $21,350.75 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Scientific Affairs, LLC $27,000.00 12/18/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941406
Principal investigator 1 Janssen Scientific Affairs, LLC $15,000.00 11/05/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941431
Principal investigator 1 Janssen Scientific Affairs, LLC $33,000.00 09/18/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941418
Principal investigator 1 Janssen Scientific Affairs, LLC $75,000.00 08/28/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941441
Principal investigator 1 Eli Lilly and Company $13,319.00 06/10/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187889048
Principal investigator 1 Janssen Scientific Affairs, LLC $2,000.00 05/29/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941464
Principal investigator 1 Janssen Scientific Affairs, LLC $60,000.00 05/22/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941451
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $70,822.25 05/06/2025 Non-covered Recipient Entity
Florida Cancer Specialists - South
Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer (CA245-0001) No dispute reported 06/30/2026 1235997333
Principal investigator 1 Eli Lilly and Company $16,991.50 03/31/2025 Non-covered Recipient Entity
FLORIDA CANCER SPECIALISTS
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187880081
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $434.58 02/25/2025 Non-covered Recipient Entity
Florida Cancer Specialists - South
Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer (CA245-0001) No dispute reported 06/30/2026 1235997335
Principal investigator 1 Eli Lilly and Company $120.60 02/25/2025 Non-covered Recipient Entity
FLORIDA CANCER SPECIALISTS
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187881536